期刊文献+

强化阿托伐他汀对不稳定性心绞痛患者介入治疗围术期Sprouty2表达的影响 被引量:10

Effect of intensive atorvastatin on expression of Sprouty2 in unstable angina pectoris patients on perioperative PCI
下载PDF
导出
摘要 目的 探讨强化剂量阿托伐他汀对不稳定性心绞痛患者PCI围术期CD4 T淋巴细胞Sprouty2表达的影响.方法 选择入住我院不稳定性心绞痛患者70例,随机分为强化他汀组35例(术前80 mg/d,术后40 mg/d)和常规他汀组35例(手术前后均20 mg/d).分别于PCI术前(入院时未服用他汀)、术后16~24 h用免疫磁珠法分选出CD4 T淋巴细胞,荧光定量PCR检测Sprouty2 mRNA表达;免疫印迹法检测Sprouty2蛋白表达;ELISA检测TNF-α及白细胞介素(IL) 10的表达.结果 与术前比较,强化他汀组术后Sprouty2 mRNA、Sprouty2蛋白表达、IL-10明显升高,TNF-α明显下降(P<0.05);常规他汀组术后Sprouty2 mRNA、IL-10虽有升高趋势,TNF-α虽有下降趋势,但差异均无统计学意义(P>0.05).直线相关分析显示,TNF-α与Sprouty2表达量呈负相关(r=-0.836,P<0.01);IL-10与Sprouty2表达量呈正相关(r=0.754,P<0.05).结论 强化剂量的阿托伐他汀可以通过上调CD4 T淋巴细胞Sprouty2的表达,升高IL-10,降低TNF-α,从而减少PCI术后心肌的炎性反应. Objective To study the effect of intensive atorvastatin on expression of Sprouty2 in unstable angina pectoris patients on perioperative PCI.Methods Seventy unstable angina pectoris patients admitted to our hospital were randomly divided into intensive atorvastatin dose treatment group and routine atorvastatin dose treatment group (35 in each group).Patients in intensive atorvastatin dose treatment group received 80 mg atorvastatin/d and those in routine atorvastatin dose treatment group administered 20 mg atorvastatin/d.Peripheral blood samples were taken before PCI and 16-24 h after PCI.CD4T cells were isolated with a magnetic cell sorting system.Expression of Sprouty2,TNF-α and IL-10 was detected by RFQ-PCR,Western blot and ELISA,respectively.Results The Sprouty2 mRNA and protein and IL-10 expression levels were significantly higher while the TNF-α expression level was significantly lower in intensive atorvastatin dose treatment group after PCI than before PCI (P〈0.05).Linear correlation analysis showed that the TNF-α expression level was negatively related with the Sprouty2 protein expression level while the IL-10 expression level was positively related with the Sprouty2 protein expression level (r=-0.836,P〈0.01 ;r=0.754,P〈0.05).Conclusion Intensiv atorvastatin increases the IL-10 expression level and decreases the TNF-α expression level by upregulating the Sprouty2 expression level,thus reducing the myocardial inflammatory reactions after PCI.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2014年第3期243-247,共5页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81260042) 广西硕士研究生科研创新项目(YCSZ2013033)
关键词 心绞痛 不稳定型 T淋巴细胞 C反应蛋白质 肿瘤坏死因子Α 白细胞介素10 降血脂药 angina, unstable T-lymphocytes C-reactive protein tumor necrosis factor-alpha interleukin-10 antilipemic agents
  • 相关文献

参考文献1

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374. 被引量:1
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840. 被引量:1
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176. 被引量:1
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339. 被引量:1
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502. 被引量:1
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533. 被引量:1
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924. 被引量:1
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505. 被引量:1
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497. 被引量:1

共引文献2138

同被引文献102

引证文献10

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部